FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings.

Adults hospitalised with COVID face a higher incidence of gastrointestinal bleeding than those not hospitalised.

A systematic review of 57 COVID-19 AI studies found that 80.7 percent relied only on internal validation, exposing a ...

Five years after the first cases, patients with long Covid continue to go through months or years before receiving a diagnosis. Publications are increasing in number, and clinical recommendations ...

Long Covid — the name adopted for cases of prolonged symptoms after an acute bout of Covid-19 — is an umbrella diagnosis covering a broad range of clinical presentations and abnormal biological ...

Syndromic multiplex diagnostics can lower costs, improve outcomes and combat Anti Microbial Resistance as Point of Care Testing and Molecular Diagnostics converge.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

Physician-diagnosed long COVID is linked to a higher risk for incident hypertension among non-hospitalised adults.

Long COVID has debilitating effects but is inconsistently diagnosed because of subjective criteria, limited treatments, and variations in health care access. We analyzed electronic health records from ...